
China’s National Medical Products Administration (NMPA) has approved the launch of the country’s first self-developed 13-valent pneumonia vaccine to protect …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

